Vojenská lékařská fakulta, Univerzita obrany

Ústav klinické mikrobiologie LF HK UK a FN HK

Klinika anesteziologie, resuscitace a intenzivní medicíny LF HK UK a FN HK

A phase 3b, open-label, multi-country, multi-centre, long-term follow-up study of ZOSTER-049 (follow-up of ZOSTER- 006/022 studies) to assess the prophylactic efficacy, safety and persistence of immune response of a Herpes Zoster subunit vaccine and assessment of persistence of immune response and safety of 1 or 2 additional doses administered in ZOSTER-049 in 2 subgroups of older adults.

Grant - ECDC: PERTINENT sentinel pilot surveillance systém. Incidence and severity of pertusis hospitalizations in infants.

A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, OBSERVER-BLINDED TRIAL TO ASSESS THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MenABCWY IN HEALTHY PARTICIPANTS ≥10 TO <26 YEARS OF AGE